Cargando…
Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials
Precision medicine in oncology promises the matching of genomic, molecular, and clinical data with underlying mechanisms of a range of novel anticancer therapeutics to develop more rational and effective antitumor strategies in a timely manner. However, despite the remarkable progress made in the un...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648610/ https://www.ncbi.nlm.nih.gov/pubmed/26609214 http://dx.doi.org/10.4137/TOG.S30533 |